Larson, Sarah
https://orcid.org/0000-0002-4335-2925
Mayo Clinic
University of California, Los Angeles
Citations 12
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Kumar, Shaji , Adekola, Kehinde , Anderson, Larry D. , Castillo, Jorge J. , Chandler, Jason C., Costello, Caitlin , Efebera, Yvonne A. , Faiman, Matthew , Garfall, Alfred L. , Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Shain, Kenneth H. , Sborov, Douglas W. , Stockerl‐Goldstein, Keith , Weber, Donna, Keller, Jennifer , Holmberg, Leona , Castillo, Jorge J , Anderson, Larry D , Garfall, Alfred L , Callander, Natalie S. , Baljević, Muhamed , Campagnaro, Erica , Kang, Yubin , Martin, Thomas G. , Kumar, Rashmi , Stockerl-Goldstein, Keith
Journal of the National Comprehensive Cancer Network | December 7, 2020 | Volume: 18 | Issue: 12 | Pages: 1685-1717
Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.
A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.
Cornell, Robert F. , Bishop, Michael R. , Larson, Sarah , Borrello, Ivan , Kumar, Shaji , Rossi, John M. , Thomrongsith, Lisa, Xue, Allen , Roberts, Zachary , Locke, Frederick L. , Bishop, Michael Russell , Orlowski, Robert Z. , Giralt, Sergio , Nooka, Ajay K. , Raje, Noopur
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS3103-TPS3103